FDA Inspection 1244967 — NAVISWISS AG

NAVISWISS AG — FEI 3017123055

The FDA completed an inspection of NAVISWISS AG on July 25, 2024 in Brugg Ag. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 25, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Compliance: Devices
Location
Brugg Ag (Switzerland)

Citations

IDCFRDescription
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate